Recently, we identified in the bullfrog brain a novel neuropeptide with a C-terminal Leu-Pro-Leu-Arg-Phe-NH 2 sequence. This amphibian neuropeptide was shown to stimulate growth hormone (GH) release in vitro and in vivo and so was designated frog GH-releasing peptide (fGRP). In this study, we cloned a cDNA encoding fGRP from the bullfrog brain by a combination of 3 and 5 rapid amplification of cDNA ends (RACE). The deduced fGRP precursor consisted of 221 amino acid residues, encoding one fGRP and three putative fGRP-related peptides that included Leu-Pro-Xaa-Arg-Phe-NH 2 (Xaa=Leu or Gln) at their C-termini. All these peptide sequences were flanked by a glycine C-terminal amidation signal and a single basic amino acid on each end as an endoproteolytic site. Northern blot analysis detected a single band of approximately 1·0 kb, indicating that no alternatively spliced forms were present. Such an apparent migration was in agreement with the estimated length of the cDNA, 902 bp. In situ hybridization further revealed the cellular localization of fGRP mRNA in the suprachiasmatic nucleus in the hypothalamus. In addition to fGRP, its related peptides may be hypothalamic factors involved in pituitary hormone secretion.
Introduction
It has been established that in a variety of vertebrates hypothalamic neurons produce neuropeptides, each regulating the secretion of a particular pituitary hormone. In amphibians, growth hormone (GH) secretion from the somatotrophs is known to be under dual control: stimulatory and inhibitory. As stimulating factors, GH-releasing hormone (GHRH; for a review, see Montero et al. 2000) , pituitary adenylate cyclase-activating polypeptide (PACAP; Martinez-Fuentes et al. 1994 , Montero et al. 2000 , and ghrelin (Kaiya et al. 2001 ) of amphibian origin have been nominated. As an inhibiting factor, frog somatostatin (Jeandel et al. 1998 ) has been described.
Since the molluscan neuropeptide Phe-Met-Arg-Phe-NH 2 (FMRFamide) was found in the ganglia of the venus clam (Price & Greenberg 1977) , immunohistochemical studies using the antiserum against FMRFamide have provided information that the vertebrate hypothalamus possesses some unknown neuropeptide similar to FMRFamide found in invertebrates. Recently, neuropeptides having the RFamide motif at their C-termini (RFamide peptides) have been identified in the brains of several vertebrates. For instance, Leu-Pro-Leu-Arg-Phe-NH 2 (LPLRFamide), a chicken pentapeptide, was purified as the first RFamide peptide found in the vertebrate brain (Dockray et al. 1983) . Two pain modulatory neuropeptides FF and AF (Yang et al. 1985) , prolactin-releasing peptide (PrRP; Hinuma et al. 1998) , and its fish counterpart, Carassius RFamide (Fujimoto et al. 1998) , are also RFamide peptides. These RFamide peptides have been shown to play some important physiological roles in neuroendocrine, behavioral, sensory and autonomic functions (Panula et al. 1996 .
On the other hand, we previously identified SIKPSAYLPLRF-NH 2 , a novel hypothalamic RFamide peptide, which inhibited gonadotropin release in the quail and we termed this dodecapeptide gonadotropininhibitory hormone (GnIH; Tsutsui et al. 2000) . Molecular cloning of cDNA encoding GnIH from the quail brain revealed that it encoded GnIH and its related peptides (GnIH-RP-1 and GnIH-RP-2), which contained a C-terminal LPXRF-NH 2 (X=L or Q) sequence (Satake et al. 2001) . The chicken pentapeptide LPLRFamide (Dockray et al. 1983 ) may be a fragment of GnIH (Satake et al. 2001) . In addition, cDNAs encoding novel RFamide-related peptides (RFRPs) similar to GnIH were reported to exist in mammalian brains, based on the results of a gene database search , and the deduced RFRPs were suggested to participate in neuroendocrine and pain mechanisms (Liu et al. 2001) in rodents. Two peptides have been predicted to be encoded in the cDNA of rodent RFRPs. Furthermore, we recently identified the octadecapeptide ANMEAGTMSHFPSLPQRF-NH 2 as one of the rodent RFRPs . In addition, a pentatriacontapeptide (SLTFEEVKDWAPKIKMNKPV VNKMPPSAANLPLRF-NH 2 ) has been purified as one of the bovine RFRPs (Fukusumi et al. 2001) . Collectively, these RFamide peptides identified in the brain of higher vertebrates are characterized by the LPXRFamide motif at their C-termini (LPXRFamide peptides).
In view of immunohistochemical findings indicating that some of the FMRFamide-like immunoreactive neurons project to the hypothalamic region close to the pituitary in amphibians (D'Aniello et al. 1996 , Pinelli et al. 1999 , we looked for a novel amphibian RFamide peptide existing in the bullfrog hypothalamus. As a result, a dodecapeptide, SLKPAANLPLRF-NH 2 with a C-terminal LPLRFamide motif, was isolated (Koda et al. 2002) . Interestingly, this peptide stimulated the release of GH from the bullfrog pituitary and was designated as frog GH-releasing peptide (fGRP; Koda et al. 2002) . With these findings as a background, in the present study we sought and identified a cDNA encoding the fGRP precursor polypeptide as the next step to investigate further the physiological roles and biochemical characteristics of fGRP, which possibly contributes to the establishment of a novel regulatory system of GH release. Here we describe the fGRP cDNA sequence and the localization of the mRNA in the hypothalamus by in situ hybridization.
Materials and Methods

RNA preparation
Adult bullfrogs (Rana catesbeiana) were used in this study. The experimental protocol was approved in accordance with the Guide for the Care and Use of Laboratory Animals prepared by Hiroshima University, Japan. Total RNA of the diencephalon was extracted by the guanidium thiocyanate-phenol-chloroform extraction method (Chomczynski & Sacchi 1987) , and the poly(A)+RNA was then isolated with Oligotex-(dT) 30 (Daiichikagaku, Tokyo, Japan) in accordance with the manufacturer's instructions.
Amplification of the partial fGRP cDNA fragment
All PCR amplifications were carried out in a reaction mixture containing Taq polymerase (Ex Taq polymerase (Takara Shuzo, Kyoto, Japan), PfuTurbo polymerase (STRATAGENE, La Jolla, CA, USA) or gene Taq polymerase (NIPPON GENE, Tokyo, Japan)) and 0·2 mM dNTP on a thermal cycler (Program Temp Control System PC-700, ASTEC, Fukuoka, Japan). Firststrand cDNA was synthesized with the oligo (dT)-anchor primer supplied in the 5 /3 rapid amplification of cDNA ends (RACE) kit (Roche Diagnostics, Basel, Switzerland) and amplified with the anchor primer (Roche Diagnostics) and the first degenerate primers 5 -(T/C)TIAA(A/G) CCIGCIGCIAA(T/C)(T/C)TICC-3 (I represents inosine), corresponding to the fGRP sequence Leu (Koda et al. 2002) . Both first-round and second-round PCRs consisted of 30 cycles for 30 s at 94 C, 30 s at 51 C, and 1 min at 72 C (11 min for the last cycle). The second-round PCR products were subcloned into a TA-cloning vector in accordance with the manufacturer's instructions (Invitrogen, San Diego, CA, USA). The DNA inserts of the positive clones were amplified by PCR with universal M13 primers.
Determination of the 5 -end sequence of fGRP cDNA
Template cDNA was synthesized with an oligonucleotide primer complementary to nt 580-599 (5 -TTCAATTC TAGAGGATGGGA-3 ); this synthesis was followed by dA-tailing of the cDNA with dATP and terminal transferase (Roche Diagnostics). The tailed cDNA was amplified with the oligo(dT)-anchor primer and gene-specific primer 1 (5 -GACTTTAGTCTTGCCAGACA-3 , complementary to nt 428-447); this was followed by further amplification of the first-round PCR products with the anchor primer and gene-specific primer 2 (5 -GGGAAT GCTTTTGGCTATTT-3 , complementary to nt 380-399). Both first-round and second-round PCRs were performed for 35 cycles consisting of 1 min at 94 C, 1 min at 55 C, and 1 min at 72 C (11 min for the last cycle). The second-round PCR products were subcloned into a pPCR-Script Amp SK(+) cloning vector in accordance with the manufacturer's instructions (STRATAGENE), and the inserts were amplified as described above.
DNA sequencing
All nucleotide sequences were determined with an ABI PRISM Dye terminator cycle sequencing ready reaction kit (PE-Biosystems, Foster City, CA, USA) and a model 373A automated DNA sequencer (PE-Biosystems), and then analyzed with DNASIS-MAC software (Hitachi Software Engineering, Kanagawa, Japan). Universal M13 primers or gene-specific primers were used to sequence both strands. 
Northern blot analysis
A digoxigenin (DIG)-labeled antisense RNA probe was produced with an RNA labeling kit (Roche Diagnostics) from a part of the fGRP precursor cDNA (complementary to nt 2-855, including all open reading frames) and used for Northern blot analysis. mRNA was separated on a denaturing 1% (w/v) agarose/formaldehyde gel and fixed on a Hybond N+ membrane (Amersham Pharmacia Life Science, Uppsala, Sweden) by u.v. irradiation. Hybridization and detection were performed in accordance with the manufacturer's standard procedure (Roche Diagnostics). RNA size was estimated with DIG-labeled RNA molecular markers (Roche Diagnostics).
In situ hybridization of fGRP mRNA
The site of fGRP mRNA expression in the brain was localized by in situ hybridization. In brief, adult bullfrogs were killed by decapitation. After dissection from the skull, the brains were fixed in 4% paraformaldehyde in PBS (pH 7·3) overnight at 4 C and then soaked in a refrigerated sucrose solution (30% sucrose in PBS) until they sank. Whole brains were embedded in OCT compound (Miles Inc., Elkhart, IN, USA) and freezesectioned frontally or sagittally at a 10 µm thickness with a cryostat at 20 C. The sections were placed onto 3-aminopropyltriethoxysilane-coated slides. In situ hybridization was carried out according to our previous method (Ukena et al. 1999 , Matsunaga et al. 2001 ) using the DIG-labeled antisense RNA probe, which was also used as a probe in the Northern blot hybridization.
Control for specificity of the in situ hybridization of fGRP mRNA was performed by using the DIGlabeled sense RNA probe, which was complementary to a common sequence of the antisense probe.
Immunohistochemistry of fGRP
Immunohistochemical analysis was performed as previously described (Koda et al. 2002) . In brief, adult bullfrogs were killed by decapitation and the brains were fixed as described above. Frontal or sagittal sections (10 µm thickness) of the brain were made with a cryostat at 20 C. After nonspecific binding components had been blocked, the sections were immersed with the antiserum raised against fGRP (Koda et al. 2002) at a dilution of 1:1000 overnight at 4 C and subsequently with rhodamine-conjugated goat anti-rabbit IgG. The localization of immunoreactive cell bodies and fibers in the bullfrog brain were examined with a Nikon fluorescence microscope. The specificity of the staining was assessed by substituting the antiserum with antiserum (1:1000 dilution) that had been preabsorbed with fGRP at a saturating concentration (20 µg synthetic fGRP/ml) overnight before use (see Koda et al. 2002) .
Results
Characterization of cDNA encoding fGRP precursor polypeptide
In an attempt to obtain fGRP precursor polypeptide cDNA fragments from the bullfrog brain, we initially performed an RT-PCR experiment with degenerate primers corresponding to the partial fGRP sequence -Phe 12 -Gly 13 and the same anchor primer. Here the C-terminal amide group was thought to be derived from a C-terminal Gly residue, which is known to be a typical amidation signal (Bradbury et al. 1982 , Suzuki et al. 1990 , Eipper et al. 1991 . Electrophoresis of the nested PCR mixture revealed a major product of approximately 0·65 kb (results not shown). The predicted amino acid sequence included three copies of the potential RFamide peptide sequence LPQRFG or LPLRFG downstream of the partial fGRP sequence derived from the second-round PCR primer, implying that this cDNA clone encoded also an RFamide peptide including a C-terminal sequence similar to that of fGRP (LPLRF-NH 2 ). To determine whether the cDNA clones included also a fGRP sequence, we performed 5 RACE with specific primers for the clone. A single product of approximately 0·4 kb (results not shown) was obtained and sequenced, revealing that these cDNA clones contained a fGRP sequence. The entire fGRP precursor cDNA was identified by combining nucleotide sequences determined by these RACE experiments. Figure 1 shows that the deduced fGRP precursor encoded one fGRP and three putative gene-related peptide (fGRP-RP-1, -RP-2 and -RP-3) sequences that included LPXRF (X=L or Q) at their C-termini. The fGRP precursor cDNA was composed of 902 nt containing a short 5 untranslated sequence of 9 bp, a single open reading frame of 663 bp, and a 3 untranslated sequence of 230 bp with a poly(A) tail of various lengths (Fig. 1) . The open reading frame region began with a start codon at position 10 and terminated with a TAG stop codon at position 673. The nucleotide sequence data reported will appear in DDBJ, EMBL and Gene Bank Nucleotide Sequence Databases under the accession number AB080743.
Detection of fGRP transcript in the frog brain
Northern blot analysis of poly(A)+ RNA detected a single band of approximately 1·0 kb in the bullfrog brain (Fig. 2) , indicating that no alternatively spliced forms were present. In addition, the apparent migration of approximately 1·0 kb was in good agreement with the estimated length of the cDNA, 902 bp. This result confirmed that the cDNA clone identified here included a full-length nucleotide sequence encoding the precursor of fGRP.
Cellular localization of fGRP mRNA in the frog brain
In situ hybridization of fGRP mRNA was examined in the bullfrog brain by using an RNA probe with a sequence complementary to that of the fGRP precursor mRNA. Expression was finally detected by enzyme immunohistochemistry. An intense expression of fGRP mRNA was detected only in the suprachiasmatic nucleus (SCN) in the hypothalamus ( Fig. 3a and c) . The control study using the sense RNA probe resulted in the complete absence of the fGRP mRNA expression in the SCN (Fig. 3b) , suggesting that the reaction was specific for fGRP mRNA. Furthermore, the SCN cells expressing fGRP mRNA (Fig. 3c) were also stained by the antiserum raised against fGRP (Fig. 3d) . A complete absence of such an immunoreaction in the SCN cells was observed by preincubation of the antiserum with synthetic fGRP (data not shown; see Koda et al. 2002) .
Discussion
Recently, we identified a novel hypothalamic neuropeptide stimulating GH release from the bullfrog pituitary in vitro and in vivo, and therefore designated it fGRP (Koda et al. 2002) . This peptide was characterized by a structure including the C-terminal LPLRF-NH 2 motif (Koda et al. 2002) . In the present study, we determined the fGRP cDNA sequence and the localization of the transcript in the bullfrog brain as the next step. We first identified a cDNA encoding fGRP from the bullfrog brain by a combination of 3 and 5 RACE. We predicted that the fGRP transcript would be translated with Met 1 , because a hydropathy plot analysis of the fGRP precursor demonstrated that the most hydrophobic moiety, which is typical in a signal peptide region, followed Met 1 . The cleavage site of the signal peptide was the Phe 25 -Ala 26 bond. The deduced precursor polypeptide consisted of 221 amino acid residues, encoding one fGRP and three putative gene-related peptide sequences, i.e. fGRP-RP-1, -2 and -3 (Fig. 1) . All four peptides shared the C-terminal sequence LPXRF motif (with X representing L in fGRP and fGRP-RP-3, and Q in fGRP-RP-1 and fGRP-RP-2). In the frog, it has been demonstrated that the proprotein convertases PC1 and PC2, which are responsible for the processing of neuropeptide precursors, are abundantly expressed in the brain including the hypothalamus (Vieau et al. 1998 , Gangnon et al. 1999 . Several proprotein convertases (PCs) are usually considered to recognize and cleave a precursor polypeptide at the Lys/Arg-(Xaa)n-Lys/Arg sequence (n=0, 2, 4 or 6; reviewed in Seidah & Chrétien 1999) . Their sequences of putative fGRP-RP-1, -2 and -3 are flanked on both ends by the typical endoproteolytic sequences, i.e. KIAK or RFGR (Fig. 1) , suggesting that mature peptides may be generated. Although fGRP (SLKPAANLPLRF-NH 2 ) purified previously has the cleavage sequences of RSLK and RFGR in the precursor polypeptide, the N-terminal cleavage does not occur between Lys and Pro (Fig. 1) . Therefore, some other N-terminal processing mechanism(s) may be present in this precursor polypeptide. On the other hand, Gly preceding the C-terminal cleavage site may serve as a C-terminal amidation signal (Bradbury et al. 1982 , Suzuki et al. 1990 , Eipper et al. 1991 . Future study is required to characterize mature endogenous fGRP-RPs by mass spectrometric analysis and clarify their biological functions.
Identification of the cells expressing fGRP mRNA in the brain must be taken into account when studying the action of neuropeptides. In the present study, we therefore characterized the site showing the expression of fGRP mRNA by in situ hybridization. The fGRP mRNA expression was localized in the SCN in the bullfrog hypothalamus. The control study using a sense RNA probe resulted in a complete absence of the fGRP mRNA expression, suggesting the validity of the in situ hybridization technique. In our previous study (Koda et al. 2002) , the cell bodies and terminals containing fGRP were localized immunohistochemically in the SCN and median eminence (ME) respectively. It was demonstrated earlier that the frog ME receives innervation from SCN neurons (Carr et al. 1991 , D'Aniello et al. 1996 . Thus the present results obtained by in situ hybridization analysis are in agreement with the previous immunohistochemical findings (Koda et al. 2002) . Taken together, it is possible that fGRP acts as an endogenous ligand in the bullfrog hypothalamo-hypophysial system. Although immunoreactive cell bodies were found not only in the SCN but 
